These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1463684)

  • 21. NK cell activity in asbestosis.
    Yoneda T; Kitamura H; Narita N; Mikami R; Yokoyama K
    Eur J Respir Dis; 1986 Jan; 68(1):64-7. PubMed ID: 3948935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced killer cell activity of lymphocytes from patients with asbestosis.
    Kubota M; Kagamimori S; Yokoyama K; Okada A
    Br J Ind Med; 1985 Apr; 42(4):276-80. PubMed ID: 3978049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome.
    Carbone J; Gallego A; Lanio N; Navarro J; Orera M; Aguaron A; Fernandez-Cruz E; Sarmiento E
    J Rheumatol; 2009 Jun; 36(6):1217-25. PubMed ID: 19332638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte subsets in primary immune thrombocytopenia.
    Rong W; Yan-xiang Z; Shan-shan X; Ju-mei S
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):816-9. PubMed ID: 24911458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An epidemiological survey of immunological abnormalities in asbestos workers. I. Nonorgan and organ-specific autoantibodies.
    Lange A
    Environ Res; 1980 Jun; 22(1):162-75. PubMed ID: 6968265
    [No Abstract]   [Full Text] [Related]  

  • 26. Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus.
    Erkeller-Yüsel F; Hulstaart F; Hannet I; Isenberg D; Lydyard P
    Lupus; 1993 Aug; 2(4):227-31. PubMed ID: 8268970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of asbestos on lymphoid cell functions. 1. The NK cell activity and its relation to interferon and asbestos].
    Kubota M
    Nihon Eiseigaku Zasshi; 1983 Jun; 38(2):623-31. PubMed ID: 6197545
    [No Abstract]   [Full Text] [Related]  

  • 28. Asbestos exposure as a cause of immunological stimulation.
    Huuskonen MS; Räsänen JA; Härkönen H; Asp S
    Scand J Respir Dis; 1978; 59(6):326-32. PubMed ID: 311941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The alveolar macrophage: immune derangement and asbestos-related malignancy.
    Kagan E
    Semin Oncol; 1981 Sep; 8(3):258-67. PubMed ID: 7280710
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemophagocytic syndrome associated with aggressive natural killer cell leukemia.
    Okuda T; Sakamoto S; Deguchi T; Misawa S; Kashima K; Yoshihara T; Ikushima S; Hibi S; Imashuku S
    Am J Hematol; 1991 Dec; 38(4):321-3. PubMed ID: 1746541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental factors and human health: fibrous and particulate substance-induced immunological disorders and construction of a health-promoting living environment.
    Otsuki T; Matsuzaki H; Lee S; Kumagai-Takei N; Yamamoto S; Hatayama T; Yoshitome K; Nishimura Y
    Environ Health Prev Med; 2016 Mar; 21(2):71-81. PubMed ID: 26663174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis.
    Langewouters AM; van Erp PE; de Jong EM; van de Kerkhof PC
    Arch Dermatol Res; 2008 Mar; 300(3):107-13. PubMed ID: 18157542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asbestos and cancer: human natural killer cell activity is suppressed by asbestos fibers but can be restored by recombinant interleukin-2.
    Robinson BW
    Am Rev Respir Dis; 1989 Apr; 139(4):897-901. PubMed ID: 2784645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological monitoring in workers occupationally exposed to asbestos.
    Ilavská S; Jahnová E; Tulinská J; Horváthová M; Dusinská M; Wsolová L; Kyrtopoulos SA; Fuortes L
    Toxicology; 2005 Jan; 206(2):299-308. PubMed ID: 15588921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4.
    Garcia JG; Griffith DE; Cohen AB; Callahan KS
    Am Rev Respir Dis; 1989 Jun; 139(6):1494-501. PubMed ID: 2543249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinicopathologic significance of lymphocyte subsets in acute myeloid leukemia.
    Alcasid M; Ma L; Gotlib JR; Arber DA; Ohgami RS
    Int J Lab Hematol; 2017 Apr; 39(2):129-136. PubMed ID: 28133918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary adrenal natural killer/T-cell nasal type lymphoma: first case report in adults.
    Thompson MA; Habra MA; Routbort MJ; Holsinger FC; Perrier ND; Waguespack SG; Rodriguez MA
    Am J Hematol; 2007 Apr; 82(4):299-303. PubMed ID: 17094095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consequences of long-lasting asbestos-exposure: peripheral blood parameters in shipyard workers with and without asbestosis.
    Trosić I; Pisl Z
    Exp Toxicol Pathol; 1995 May; 47(2-3):212-6. PubMed ID: 7580111
    [No Abstract]   [Full Text] [Related]  

  • 39. Macrophage activity in asbestos related diseases.
    Tarkowski M; Górski P
    Pol J Occup Med Environ Health; 1991; 4(2):115-25. PubMed ID: 1799637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of in vitro immunoglobulin secretion by amosite asbestos.
    Lawrence EC; McClung HW; Wilson RK; Key MM; Dodson RM; Hurst GA
    J Immunol; 1982 Nov; 129(5):1931-5. PubMed ID: 6288799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.